Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor.

14:33 EDT 20th August 2014 | BioPortfolio

Summary of "Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor."

No Summary Available

Affiliation

Servicio de Endocrinología y Nutrición, Hospital La Moraleja, Madrid, España.

Journal Details

This article was published in the following journal.

Name: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
ISSN: 1579-2021
Pages:

Links

PubMed Articles [13095 Associated PubMed Articles listed on BioPortfolio]

Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children.

To investigate the impact of new-onset diabetic ketoacidosis (DKA) during childhood on brain morphology and function.

Streptozotocin-induced diabetic ketoacidosis in a patient with metastatic islet-cell carcinoma.

Here we report a severe life-threatening complication of treatment with streptozotocin in a patient with pancreatic island-cell carcinoma. The patient was admitted to the intensive care unit with seve...

Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics.

Diabetic ketoacidosis (DKA) is a potentially life-threatening acute complication of type 1 diabetes mellitus (T1DM). Although the frequency of DKA as first manifestation of T1DM is higher in developin...

Extrapontine Myelinolysis in an 18-Month-Old Boy With Diabetic Ketoacidosis: Case Report and Literature Review.

Extrapontine myelinolysis is characterized by symmetric demyelination following rapid shifts in serum osmolality in the supratentorial compartment. Extrapontine myelinolysis in children is rare compar...

Lactic acidosis in diabetic ketoacidosis.

We describe the case of a 22-year-old man with insulin-dependent diabetes, who was admitted to the emergency department with hypotension, unconsciousness and a severe combined diabetic ketoacidosis (D...

Clinical Trials [4082 Associated Clinical Trials listed on BioPortfolio]

Cerebral Edema in Pediatric Diabetic Ketoacidosis

The purpose of this trial is to compare two different rates of fluid administration during diabetic ketoacidosis (DKA) treatment in children to determine which fluid administration rate is...

Use of Insulin Glargine to Treat Diabetic Ketoacidosis

The purpose of this study is to determine the effects of the addition of insulin glargine during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children. The investi...

Recombinant Human Prolactin for Lactation Induction

The purpose of the study is to assess the safety and determine the effects of the hormone prolactin on lactation (breast milk production).

Efficacy Study of Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA

The purpose of this study is to determine whether insulin administered by a subcutaneous injection is effective in the treatment of a diabetic crisis and to determine if beta-hydroxybutyra...

Recombinant Human Prolactin for Lactation Induction

The purpose of the study is to assess the safety and determine the effects of the hormone prolactin on lactation (breast milk production).

Medical and Biotech [MESH] Definitions

Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor.

Disease of the glandular, anterior portion of the pituitary (PITUITARY GLAND, ANTERIOR) resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and ADRENOCORTICOTROPIC HORMONE. Hyperpituitarism usually is caused by a functional ADENOMA.

A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist.

A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.

A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.

Search BioPortfolio: